Seattle, WA · Founded 2021 · Privately Held (backing)
Developer of antibody-based therapeutics designed to enable targeted and regulated treatment of diseases. Bonum Therapeutics is based in Seattle, WA and was founded in 2021. Its last reported valuation was $130 million in Nov 2022. It has raised $127 million across 3 recorded rounds; the latest was a $26.9 million early-stage round in Apr 2026.
These 6 firms already write checks for companies like Bonum Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.